Urinary Catheters Pipeline Insight and Competitive Landscape 2020: Comprehensive Insights on 20+ Companies Pipeline Devices - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Urinary Catheters Pipeline Insight and Competitive Landscape 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

The Urinary Catheters-Pipeline Insight and Competitive Landscape 2020, report provides comprehensive insights on 20+ companies and 20+ pipeline devices in Urinary Catheters pipeline landscape.

Companies of devices are already trying to have many alterations to reduce the risk of trauma and infection associated with those catheters. Growing interest in advanced urinary catheters and favorable Regulatory policies are key factors that contribute to greater demand for urinary catheters which will eventually led to market boost.

Urinary Catheters Devices Competitive Assessment

This segment of the Urinary Catheters report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates and the latest news and press releases. The report also provides list of major players involved in the pipeline product development.

Product Type

There are 2 main types of urinary catheter:

• Intermittent catheters - these are temporarily inserted into the bladder and removed once the bladder is empty
• Indwelling catheters - these remain in place for many days or weeks, and are held in position by an inflated balloon in the bladder
• Product Application

Urinary Catheters can have an application in various medical conditions and diseases - Benign prostate hyperplasia, Urinary incontinence, Spinal cord injury and others, which are covered in the report.

Major Players in Urinary Catheters

There are approx. 20+ key companies which are developing the products for Urinary Catheters.

Foley-type urinary catheter: Tractivus

Tractivus has developed bacteriaphobic urinary catheter with PHOBOSTech which shows the same mechanical properties as standard devices, but it avoids bacteria colonization and biofilm formation during the urine drainage. The product increases the lifetime of the device (>30 days) without colonisation problems reducing the infection rate. Tractivus has completed an in vivo study of its PHOBOSTech technology applied to a urinary catheter where it was compared with other commercial devices:

ResQ Catheter: Control Flo Medical

The ResQ Catheter is an innovative urinary blockage and drainage device that allows voluntary urination for retention sufferers and prevents unwanted leakage of urine. It is worn internally. Patients operate a simple valve to void their bladder whenever and wherever it is convenient. The ResQ Catheter device uses unique technology to help urinary incontinent and intermittent catheter patients. This product is not marketed in the USA nor internationally. It has not been approved by FDA or any other regulatory agency.

Urinary Catheters Devices Competitive Benchmarking

This segment of the reports provides analysis of the pipeline report to give a clear understanding of the comparative analysis.

The analysis is based on

• Brand Positioning of Leading companies
• Application
• Industry Collaborations

Urinary Catheters Devices: Commercialization Activity

This segment of the report provides a detailed list of any commercial activity in the field of urinary catheters devices ranging from collaboration, mergers and acquisition, recent breakthrough among others.

Development Activities

• In Oct 2019, the most notable development in catheter-related products so far is the hydrophilic coating. Fortunately, in Korea, the national insurance has recently covered the cost for CIC catheters in SCI patients with NB. In several small-scale studies, hydrophilic coating catheter is thought to reduce the discomfort and urethral mucosa damage to some extent. Therefore, such hydrophilic coating catheter may be useful if at least existing catheter is difficult to insert into the urethra, if the patient experienced urethral damage, or frequent recurrence of UTI.
• In July 2019, a new type of female indwelling catheter technology reduced inpatient catheter-associated UTIs, or CAUTIs, by 51.7%, according to data presented at the annual conference of the Association for Professionals in Infection Control and Epidemiology. These data mirror findings of a second study presented at APIC that similarly showed a decrease in indwelling urinary catheter use in female patients - but not a reduction of CAUTIs - after external catheters were used.

Urinary Catheters Devices: Regulatory

For urine collector and accessories intended to be connected to an indwelling catheter. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to 876.9. under CFR - Code of Federal Regulations Title 21.

Key Players

• Bactiguard Holding AB
• Biocrede Inc
• BioModics ApS
• Brighton Development LLC
• Control Flo Medical LLC
• Flat Medical Inc
• FocusStart LLC
• InterVaal Pte Ltd
• Leading Age Supplies LLC
• N8 Medical Inc
• Olympus Medical Systems Corp
• Provenmed
• Pyriscence LLC
• Riocath Global AS
• Sharklet Technologies Inc
• Tractivus SL

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/ubmwjx